Ajanta Pharma USA Inc recalls
5 recall notices naming Ajanta Pharma USA Inc since January 2025, in United States. The most recent was published 7 Oct 2026.
Latest recalls (5)
- Ajanta Pharma USA Inc recalls Ranolazine Extended-Release TabletsFDAFailed Dissolution Specifications: below specification
- Ajanta Pharma USA Inc recalls Fluphenazine Hydrochloride TabletsFDAFailed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability.…
- Ajanta Pharma USA Inc recalls Fenofibrate CapsulesFDACGMP Deviations
- Ajanta Pharma USA Inc recalls Aripiprazole Tablets USPFDAProduct Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
- Ajanta Pharma Ltd. recalls Duloxetine Delayed-Release CapsulesFDACGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month…